JOHNSON & JOHNSON
JNJ
56 insider filings · Latest: Sep 8, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Sep 4 1:08 PM | Timothy SchmidEVP, WW Chair, MedTech | Sale | 33,597 | $274.74 | $9.2M | 25,447(D) | View → |
| Sep 2, 2026 | Sep 2 3:26 PM | Schmid Timothy | Proposed Sale | 33,597 | $274.74 | $9.2M | — | View → |
| Aug 17, 2026 | Aug 18 10:31 PM | Jennifer L TaubertEVP, WWC. Innovative Medicine | Sale | 15,000 | $263.36 | $4.0M | 194,451.001(D) | View → |
| Aug 17, 2026 | Aug 17 4:51 PM | Taubert Jennifer L | Proposed Sale | 15,000 | $263.36 | $4.0M | — | View → |
| Aug 13, 2026 | Aug 14 8:35 PM | Joaquin DuatoDirector, CEO and Chairman of the Board | Sale | 123,291 | $261.17 | $32.2M | 275,967(D) | View → |
| Aug 13, 2026 | Aug 13 6:12 PM | Duato Joaquin | Proposed Sale | 123,291 | $261.17 | $32.2M | — | View → |
| Aug 5, 2026 | Aug 7 9:50 PM | Joaquin DuatoDirector, CEO and Chairman of the Board | Sale | 48,480 | $258.15 | $12.5M | 275,967(D) | View → |
| Aug 6, 2026 | Aug 7 9:44 PM | Elizabeth ForminardEVP, Chief Legal Officer | Sale | 15,918 | $257.00 | $4.1M | 16,994(D) | View → |
| Aug 6, 2026 | Aug 6 6:02 PM | Forminard Elizabeth | Proposed Sale | 15,918 | $257.00 | $4.1M | — | View → |
| Aug 5, 2026 | Aug 5 10:07 PM | Joaquin Duato | Proposed Sale | 48,480 | $254.93 | $12.4M | — | View → |
| Jul 20, 2026 | Jul 21 9:27 PM | Vanessa BroadhurstEVP, Global Corp Affairs | Sale | 23,054 | $251.27 | $5.8M | 23,003(D) | View → |
| Jul 20, 2026 | Jul 20 5:35 PM | Broadhurst Vanessa | Proposed Sale | 23,054 | $251.27 | $5.8M | — | View → |
| Jun 11, 2026 | Jun 12 9:23 PM | Kathryn E WengelEVP, Chief TO and Risk Officer | Sale | 10,000 | $241.15 | $2.4M | 114,287.874(D) | View → |
| Jun 11, 2026 | Jun 11 5:44 PM | Wengel Kathryn E | Proposed Sale | 10,000 | $240.15 | $2.4M | — | View → |
| Feb 27, 2026 | Mar 3 9:21 PM | Robert J DeckerVP Corporate Controller | Sale | 4,075 | $247.87 | $1.0M | 23,682(D) | View → |
| Feb 27, 2026 | Feb 27 7:35 PM | Decker Robert J | Proposed Sale | 4,075 | $247.87 | $1.0M | — | View → |
| Feb 20, 2026 | Feb 23 10:20 PM | Timothy SchmidEVP, WW Chair, MedTech | Sale | 1,322 | $245.66 | $324.8K | 25,447(D) | View → |
| Feb 20, 2026 | Feb 20 3:46 PM | Schmid Timothy | Proposed Sale | 1,322 | $245.66 | $324.8K | — | View → |
| Feb 17, 2026 | Feb 19 2:12 AM | James D. SwansonEVP, CIO | Sale | 20,521 | $242.70 | $5.0M | 25,698.131(D) | View → |
| Feb 13, 2026 | Feb 19 2:12 AM | James D. SwansonEVP, CIO | Sale | 41,559 | $243.73 | $10.1M | 25,020.131(D) | View → |
Page 1 of 3
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | Apr 27 10:01 PM | Paula A JohnsonDirector | Grant/Award | 975 | — | 5,359.397(D) | View → |
| Apr 23, 2026 | Apr 27 9:48 PM | Marillyn A HewsonDirector | Grant/Award | 975 | — | 15,487.939(D) | View → |
| Apr 23, 2026 | Apr 27 9:43 PM | Jennifer A DoudnaDirector | Grant/Award | 975 | — | 10,899.171(D) | View → |
| Apr 23, 2026 | Apr 27 9:38 PM | Mary C BeckerleDirector | Grant/Award | 975 | — | 16,797.739(D) | View → |
| Mar 10, 2026 | Mar 13 1:31 AM | Marillyn A HewsonDirector | Grant/Award | 206.492 | — | 14,512.94(D) | View → |
| Mar 4, 2025 | Mar 13 1:31 AM | Marillyn A HewsonDirector | Grant/Award | 75.256 | — | 14,306.449(D) | View → |
| Mar 10, 2026 | Mar 13 12:39 AM | Daniel E PintoDirector | Grant/Award | 129.058 | — | 462.069(D) | View → |
| Mar 10, 2026 | Mar 13 12:37 AM | Eugene A. WoodsDirector | Grant/Award | 154.869 | — | 5,240.094(D) | View → |
| Feb 27, 2026 | Mar 3 9:21 PM | Robert J DeckerVP Corporate Controller | Option Exercise | 4,075 | $115.67 | 0(D) | View → |
| Feb 17, 2026 | Feb 19 2:12 AM | James D. SwansonEVP, CIO | Option Exercise | 20,521 | $164.62 | 0(D) | View → |
| Feb 15, 2026 | Feb 19 2:12 AM | James D. SwansonEVP, CIO | Grant/Award | 20,846 | $243.45 | 1,397(D) | View → |
| Feb 15, 2026 | Feb 19 2:12 AM | James D. SwansonEVP, CIO | Option Exercise | 1,201 | — | 1,418(D) | View → |
| Feb 13, 2026 | Feb 19 2:12 AM | James D. SwansonEVP, CIO | Option Exercise | 51,418 | $165.89 | 0(D) | View → |
| Feb 15, 2026 | Feb 19 2:12 AM | Kathryn E WengelEVP, Chief TO and Risk Officer | Grant/Award | 18,162 | $243.45 | 1,217(D) | View → |
| Feb 15, 2026 | Feb 19 2:12 AM | Kathryn E WengelEVP, Chief TO and Risk Officer | Option Exercise | 1,241 | — | 1,268(D) | View → |
| Feb 13, 2026 | Feb 19 2:12 AM | Kathryn E WengelEVP, Chief TO and Risk Officer | Option Exercise | 14,357 | — | 0(D) | View → |
| Feb 15, 2026 | Feb 19 2:12 AM | Kristen MulhollandEVP, Chief HR Officer | Option Exercise | 994 | — | 1,150(D) | View → |
| Feb 15, 2026 | Feb 19 2:12 AM | Kristen MulhollandEVP, Chief HR Officer | Grant/Award | 21,781 | $243.45 | 1,459(D) | View → |
| Feb 13, 2026 | Feb 19 2:12 AM | Kristen MulhollandEVP, Chief HR Officer | Option Exercise | 4,012 | — | 0(D) | View → |
| Feb 17, 2026 | Feb 19 2:12 AM | Joseph J WolkExec VP, CFO | Option Exercise | 64,693 | $131.94 | 33,000(D) | View → |